# Zydus Lifesciences is set to acquire Assertio Holdings, a US pharmaceutical firm.

*biotech · news · 2026-05-13 · Devdiscourse*

## Key points

- Zydus Lifesciences will acquire Assertio Holdings for USD 166.4 million.
- The deal gives Zydus access to Assertio's commercial infrastructure in US oncology supportive care.
- The acquisition process involves a tender offer followed by a merger, pending standard closing conditions.
- The transaction is expected to close in the 2026-27 financial year, expanding Zydus's global oncology presence.

**Companies:** Zydus Lifesciences, Assertio Holdings
**Countries:** India, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3907279-zydus-lifesciences-acquires-us-pharma-firm-assertio-holdings)

---

Canonical: https://newsio.io/n/e9a26872-f31c-461b-bed8-cd00e3e8c257/zydus-lifesciences-is-set-to-acquire-assertio-holdings-a-us-pharmaceutical-firm
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works